Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2021 | 10-2020 | 07-2020 | 04-2020 | 01-2020 | |
| Sales | 513 | 0 | 0 | 0 | 0 |
| Gross Profit | 513 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,746 | 2,242 | 2,436 | 2,670 | 2,630 |
| Operating Income | -2,233 | -2,242 | -2,436 | -2,670 | -2,630 |
| Other Income | 1 | 1 | -141 | 12 | 13 |
| Pre-tax Income | -2,232 | -2,241 | -2,577 | -2,658 | -2,617 |
| Net Income Continuous | -2,232 | -2,241 | -2,577 | -2,658 | -2,617 |
| Minority Interests | -24 | -17 | -15 | -18 | -24 |
| Net Income | $-2,208 | $-2,224 | $-2,562 | $-2,640 | $-2,593 |
| EPS Basic Total Ops | -0.09 | -0.09 | -0.11 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.09 | -0.09 | -0.11 | -0.13 | -0.13 |
| EPS Diluted Total Ops | -0.09 | -0.09 | -0.11 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.09 | -0.09 | -0.11 | -0.13 | -0.13 |
| EBITDA(a) | $-2,219 | $-2,229 | $-2,414 | $-2,643 | $-2,603 |